… macht auch die Knochen brüchig. [16] Der beste Schutz vor Stürzen ist sinnvolle Aktivität, die das Cortisol senkt, die Muskeln kräftig erhält und die Motorik verbessert. So vermeiden wir den Muskelschwund im Alter (Sarkopenie).
[1] Amann-Vesti BR (2006): Klinische Pathophysiologie. Georg Thieme Verlag, S. 84.
[2] Naicker N et al. (2016): Trigonella foenum-graecum Seed Extract, 4-Hydroxyisoleucine,
and Metformin StimulateProximal Insulin Signaling and Increase Expression of Glycogenic
Enzymes and GLUT2 in HepG2 Cells. Metab Syndr Relat Disord. 14 (2):114-20. doi: 10.1089/met.2015.0081.
[3] European Scientific Cooperative on Phytotherapy: ESCOP monographs, 2nd edition (2003):
Trigonellae foenugraecisemen – Fenugreek. 511-520.
[4] Broca C et al. (1999): 4-Hydroxyisoleucine: experimental evidence of its insulinotropic
and antidiabetic properties. Am. J.Physiol. Endocrinol. Metab. 277: 617-623.
[5] Srinivasan K (2005): Plant foods in the management of diabetes mellitus: spices as be-neficial
antidiabetic food adjuncts. Int. J. Food Sci. Nutr. 56: 399-414.
[6] Deng R (2012): A review of the hypoglycemic effects of five commonly used herbal food supplements.
Recent Pat Food Nutr Agric. 4 (1): 50-60.
[7] Koupý D et al. (2015): Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus II.
Fenugreek (Trigonella foenum-graecum). Ceska Slov Farm. 64 (3): 67-71.
[8] Andreozzi P et al. (2015). The Bitter Taste Receptor Agonist Quinine Reduces Calorie Intake and Increases
the Postprandial Release of Cholecystokinin in Healthy Subjects. J Neurogastroenterol Motil. 2015 Oct;
21(4): 511–519. doi: 10.5056/ jnm15028.
[9] Yoshida R et al. (2017): The Role of Cholecystokinin in Peripheral Taste Signaling in Mice. Front Physiol.
2017 Oct 31;8:866. doi: 10.3389/fphys.2017.00866.
[10] Kim KS et al. (2014): Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste
receptor pathways. Diabetologia. 2014 Oct;57(10):2117-25. doi: 10.1007/s00125-014-3326-5.
[11] Mehnert H (2003): Diabetologie in Klinik und Praxis. Thieme.
[12] Pieper W (2012): Innere Medizin. Springer, S. 478.
[13] Kaiser H et al. (2002): Cortisontherapie: Corticoide in Klinik und Praxis. Thieme.
[14] Löscher W et al. (2016): Lehrbuch der Pharmakologie und Toxikologie für die Veterinärmedizin, 12
Endokrinpharmakologie (II). Enke, S. 347.
[15] Meyer G et al. (2003): Glukokortikoidinduzierte Insulinresistenz und Diabetes mellitus, Rezeptor-,
Postrezeptormechanismen, lokale Cortisolwirkung und neue Aspekte in der antidiabetischen Therapie. Medizinische Klinik, Volume 98, Issue 5.
[16] Bühlmann AA et al. (2013): Pathophysiologie. Springer.
